109 related articles for article (PubMed ID: 25458474)
1. Purification of equine whole IgG snake antivenom by using an aqueous two phase system as a primary purification step.
Vargas M; Segura Á; Villalta M; Herrera M; Gutiérrez JM; León G
Biologicals; 2015 Jan; 43(1):37-46. PubMed ID: 25458474
[TBL] [Abstract][Full Text] [Related]
2. Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa.
Gutiérrez JM; Rojas E; Quesada L; León G; Núñez J; Laing GD; Sasa M; Renjifo JM; Nasidi A; Warrell DA; Theakston RD; Rojas G
Trans R Soc Trop Med Hyg; 2005 Jun; 99(6):468-75. PubMed ID: 15837359
[TBL] [Abstract][Full Text] [Related]
3. Single-reagent one-step procedures for the purification of ovine IgG, F(ab')2 and Fab antivenoms by caprylic acid.
Al-Abdulla I; Casewell NR; Landon J
J Immunol Methods; 2014 Jan; 402(1-2):15-22. PubMed ID: 24246428
[TBL] [Abstract][Full Text] [Related]
4. Assessment of snake antivenom purity by comparing physicochemical and immunochemical methods.
Segura A; Herrera M; Villalta M; Vargas M; Gutiérrez JM; León G
Biologicals; 2013 Mar; 41(2):93-7. PubMed ID: 23190453
[TBL] [Abstract][Full Text] [Related]
5. Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique.
Guidolin FR; Caricati CP; Marcelino JR; da Silva WD
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004325. PubMed ID: 26730709
[TBL] [Abstract][Full Text] [Related]
6. Experimental manufacture of equine antivenom against yamakagashi (Rhabdophis tigrinus).
Morokuma K; Kobori N; Fukuda T; Uchida T; Sakai A; Toriba M; Ohkuma K; Nakai K; Kurata T; Takahashi M
Jpn J Infect Dis; 2011; 64(5):397-402. PubMed ID: 21937821
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the impact of solvent/detergent treatment on the quality and potency of a whole IgG equine antivenom.
Segura A; León G; Su CY; Gutiérrez JM; Burnouf T
Biologicals; 2009 Oct; 37(5):306-12. PubMed ID: 19540775
[TBL] [Abstract][Full Text] [Related]
8. Anticomplementary activity of equine whole IgG antivenoms: comparison of three fractionation protocols.
León G; Lomonte B; Gutiérrez JM
Toxicon; 2005 Jan; 45(1):123-8. PubMed ID: 15581691
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of caprylic acid-fractionated IgG antivenom for the treatment of Taipan (Oxyuranus scutellatus) envenoming in Papua New Guinea.
Vargas M; Segura A; Herrera M; Villalta M; Estrada R; Cerdas M; Paiva O; Matainaho T; Jensen SD; Winkel KD; León G; Gutiérrez JM; Williams DJ
PLoS Negl Trop Dis; 2011 May; 5(5):e1144. PubMed ID: 21610854
[TBL] [Abstract][Full Text] [Related]
10. Caprylic acid fractionation of hyperimmune horse plasma: description of a simple procedure for antivenom production.
Rojas G; Jiménez JM; Gutiérrez JM
Toxicon; 1994 Mar; 32(3):351-63. PubMed ID: 8016856
[TBL] [Abstract][Full Text] [Related]
11. A new ELISA for determination of potency in snake antivenoms.
Rial A; Morais V; Rossi S; Massaldi H
Toxicon; 2006 Sep; 48(4):462-6. PubMed ID: 16893558
[TBL] [Abstract][Full Text] [Related]
12. Detection of venom-antivenom (VAV) immunocomplexes in vitro as a measure of antivenom efficacy.
O'Leary MA; Isbister GK
Toxicon; 2014 Jan; 77():125-32. PubMed ID: 24252422
[TBL] [Abstract][Full Text] [Related]
13. Development of a chicken-derived antivenom against the taipan snake (Oxyuranus scutellatus) venom and comparison with an equine antivenom.
Navarro D; Vargas M; Herrera M; Segura Á; Gómez A; Villalta M; Ramírez N; Williams D; Gutiérrez JM; León G
Toxicon; 2016 Sep; 120():1-8. PubMed ID: 27373994
[TBL] [Abstract][Full Text] [Related]
14. Protein content of antivenoms and relationship with their immunochemical reactivity and neutralization assays.
de Roodt AR; Clement H; Dolab JA; Litwin S; Hajos SE; Boyer L; Alagón A
Clin Toxicol (Phila); 2014 Jul; 52(6):594-603. PubMed ID: 24940642
[TBL] [Abstract][Full Text] [Related]
15. Analysis of camelid IgG for antivenom development: Serological responses of venom-immunised camels to prepare either monospecific or polyspecific antivenoms for West Africa.
Cook DA; Owen T; Wagstaff SC; Kinne J; Wernery U; Harrison RA
Toxicon; 2010 Sep; 56(3):363-72. PubMed ID: 20362604
[TBL] [Abstract][Full Text] [Related]
16. Intravenous administration of equine-derived whole IgG antivenom does not induce early adverse reactions in non-envenomed horses and cows.
Estrada R; Herrera M; Segura A; Araya J; Boschini C; Gutiérrez JM; León G
Biologicals; 2010 Nov; 38(6):664-9. PubMed ID: 20833066
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of four Peruvian Bothrops sp. snake venoms by polyvalent antivenoms produced in Perú and Costa Rica: preclinical assessment.
Rojas E; Quesada L; Arce V; Lomonte B; Rojas G; Gutiérrez JM
Acta Trop; 2005 Jan; 93(1):85-95. PubMed ID: 15589801
[TBL] [Abstract][Full Text] [Related]
18. Low pH formulation of whole IgG antivenom: impact on quality, safety, neutralizing potency and viral inactivation.
Solano S; Segura Á; León G; Gutiérrez JM; Burnouf T
Biologicals; 2012 Mar; 40(2):129-33. PubMed ID: 22266304
[TBL] [Abstract][Full Text] [Related]
19. Quality-Related Properties of Equine Immunoglobulins Purified by Different Approaches.
Mateljak Lukačević S; Kurtović T; Lang Balija M; Brgles M; Steinberger S; Marchetti-Deschmann M; Halassy B
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33327454
[TBL] [Abstract][Full Text] [Related]
20. Effect of pepsin digestion on the antivenom activity of equine immunoglobulins.
Morais V; Massaldi H
Toxicon; 2005 Dec; 46(8):876-82. PubMed ID: 16260020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
